Videos
Managing Adverse Events in Breast Cancer Treatment
03/25/2025
Heather Moore, PharmD, BCOP, CPP, Duke Cancer Center, Durham, North Carolina, discusses some key considerations for adverse events when treating patients with breast cancer. Dr Moore focused on the novel agents that are now being used in this patient population, such as CDK4/6 inhibitors, PI3K/AKT inhibitors, and antibody-drug conjugates.
Transcript to come.
Source:
Moore H. Management of Adverse Events in Breast Cancers. Presented at 2025 Great Debates in Solid Tumors Meeting. March 22-23, 2025; New York, NY.
